GLP-1 Medications and Hair Loss: What You Need to Know

Individuals using GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro for conditions such as type 2 diabetes and obesity may experience an increased risk of hair loss, according to recent research analyzing U.S. Medical records. The risk appears within six months of starting the medication and becomes more pronounced after a year.

What the Research Shows

A study co-authored by Adam Friedman, MD, chair of the dermatology department at George Washington University, found that people taking GLP-1 medications had a higher chance of developing nonscarring hair loss, meaning the hair follicles remain intact and regrowth is possible. Researchers analyzed electronic health records from over half a million adults, matched by age, sex, race, BMI, and diabetes status, to compare GLP-1 users and non-users.

• Six Months: GLP-1 users were 26% more likely to develop nonscarring hair loss and 62% more likely to experience pattern hair thinning.
• Twelve Months: The likelihood increased to 40% for nonscarring hair loss, 64% for pattern thinning, and 76% for stress-related shedding.

The study did not find an increased risk of alopecia areata, an autoimmune form of hair loss, suggesting the issue isn’t immune-system related.

Why GLP-1s Might Impact Hair

While the study is observational and cannot definitively prove causation, its size and design strengthen the findings. Most experts believe rapid weight loss, a common effect of GLP-1 medications, is the primary driver of hair loss. This phenomenon is known as telogen effluvium – a temporary increase in hair shedding often triggered by physical stressors like illness, surgery, or significant weight change.

However, research suggests weight loss may not be the sole factor. Other potential contributors include hormonal shifts, changes in insulin signaling, metabolic stress, and direct effects on the hair follicle itself. Some individuals may experience the revealing of pre-existing, underlying pattern hair thinning that was likely to occur regardless of medication use.

Is Hair Loss from GLP-1s Permanent?

In most cases, the hair loss associated with GLP-1 medications is nonscarring and reversible. If shedding occurs, it typically improves as the body adjusts, weight stabilizes, and nutritional intake is optimized. Pattern thinning, while potentially progressive, is treatable with standard hair growth therapies.

The Role of Nutrition

Adequate calorie, protein, and micronutrient intake is crucial for hair growth. Restricting caloric intake too drastically can shift the body’s energy allocation away from non-essential processes like hair growth. Sufficient fat and nutrient intake are as well vital for hormone production, which plays a role in hair growth.

What to Do If You Experience Hair Loss

If you notice hair loss while taking a GLP-1 medication, it’s important to consult with both your prescribing physician and a dermatologist. Do not stop taking the medication without medical advice, as the metabolic and cardiovascular benefits may outweigh the risk of hair loss.

A dermatologist can diagnose the type of hair loss and evaluate thyroid levels, hormone balance, and nutritional status. Discussing the rate of weight loss with your doctor is also recommended.

Treatment Options

Treatment options for pattern thinning include topical or oral minoxidil, antihormonal therapies like spironolactone (for women), or 5-alpha reductase inhibitors such as finasteride or dutasteride.

hair loss can often be managed, and for many patients, the health benefits of GLP-1 medications remain significant. Collaboration with a board-certified dermatologist can assist mitigate this common side effect.